Kevin Lynch

Vice President and General Manager, CDMO Services

Kevin Lynch has more than 30 years of experience in the life sciences industry. Before joining Maravai in 2023, he was the Head of Operations for Millipore Sigma’s viral and gene therapies business, leading the CDMO clinical and commercial production. Prior to that, Kevin served in sales, manufacturing, operations, and business leader roles at Sartorius Stedim Biotech, Shire Pharmaceuticals, Genzyme Corporation, and Cambridge Biotech. He received his bachelor’s in biology from the University of Vermont. Kevin is a collaborative leader with extensive knowledge of biopharmaceutical processes, expertise in operational excellence, and a deep commitment to continuous process improvement, compliance, and unparalleled customer experience.